Article · 26 May 2026
Research articlePublished 30 Apr 2015
Ab initio and DFT investigation of C4 & C7 position of sialidase antiviral inhibitor
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
DANA is the first sialidase antiviral inhibitor and its C4 position plays a vital role in inhibiting the neuraminidase virus. However, C7 position remains free with involving in any receptor interaction. Hence, various substitutes were introduced at the key functional site of DANA to design new sialidase inhibitor. The investigation reveals that at the C4 position amino, guandino and thiol group improves the binding affinity. Especially guandino at the C4 position enormously increases the binding affinity and acts as promising candidate for neuraminidase antiviral inhibitor. Meanwhile the investigation at C7 position discloses that the substituents such as amino, methoxy and methyl group increases the binding affinity and could act as potential antiviral neuraminidase inhibitor
Subjects
Pharmaceutical SciencesChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Chemical and Pharmaceutical Research.
Article · 12 Mar 2025
Studies on Exploring the Efficacy of Plant Based Silver Nanoparticles in Preventing Mercuric Toxicity on Blood
Article · 10 Mar 2025
Measurement of Malondialdehyde in Plasma by High Performance Liquid Chromatography Assay in Severe Cranial Trauma at The First Week of Admission: Comatose Patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Chemical and Pharmaceutical Research
- SubjectPharmaceutical Sciences
- SubjectChemistry
- BylineArticles whose byline prints “Krishnan Chandrasekaran”